These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 17376547

  • 1. Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation.
    Patten CS, Daniels D, Suzuki A, Fluharty SJ, Yee DK.
    Regul Pept; 2007 Aug 16; 142(3):111-22. PubMed ID: 17376547
    [Abstract] [Full Text] [Related]

  • 2. The signalling profile of recombinant human orexin-2 receptor.
    Tang J, Chen J, Ramanjaneya M, Punn A, Conner AC, Randeva HS.
    Cell Signal; 2008 Sep 16; 20(9):1651-61. PubMed ID: 18599270
    [Abstract] [Full Text] [Related]

  • 3. Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.
    Herraiz C, Journé F, Ghanem G, Jiménez-Cervantes C, García-Borrón JC.
    Int J Biochem Cell Biol; 2012 Dec 16; 44(12):2244-52. PubMed ID: 23000456
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
    Mouawad R, Li Y, Anand-Srivastava MB.
    Mol Pharmacol; 2004 Apr 16; 65(4):917-24. PubMed ID: 15044621
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism.
    Rodrigues AR, Pignatelli D, Almeida H, Gouveia AM.
    Mol Cell Endocrinol; 2009 May 06; 303(1-2):74-81. PubMed ID: 19428994
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
    Galandrin S, Bouvier M.
    Mol Pharmacol; 2006 Nov 06; 70(5):1575-84. PubMed ID: 16901982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.